首页 | 本学科首页   官方微博 | 高级检索  
     


Entry of diazepam and its major metabolite into cerebrospinal fluid
Authors:David J. Greenblatt  Hermann R. Ochs  Brian L. Lloyd
Affiliation:(1) Division of Clinical Pharmacology, Department of Psychiatry, Tufts University School of Medicine, Boston, Massachusetts, USA;(2) Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA;(3) New England Medical Center Hospital, Boston, Massachusetts, USA;(4) Cardiovascular Division, Department of Medicine, Peter Bent Brigham Hospital and Harvard Medical School, Boston, Massachusetts, USA;(5) Present address: Medizinische Universitätsklinik, Bonn, West Germany;(6) Present address: Royal Perth Hospital, Perth, Western Australia
Abstract:Five dogs received a single 1.0 mg/kg dose of diazepam (DZ) IV. Concentrations of DZ and its major metabolite desmethyldiazepam (DMDZ) were simultaneously measured in plasma and cisternal cerebrospinal fluid (CSF) for up to 8 h after the dose by electron-capture gas-liquid chromatography. DZ was rapidly eliminated from plasma (half-life 0.3–1.3 h); DZ disappearance was mirrored by formation of DMDZ, which in turn was eliminated slowly. Both DZ and DMDZ rapidly penetrated CSF and concentrations in CSF declined parallel with those in plasma. Despite rapid uptake, the extent of CSF transfer of DZ and DMDZ was limited by plasma protein binding. Mean CSF: plasma concentration ratios for DZ (range 0.023–0.137) and DMDZ (range 0.047–0.119) were highly correlated with the unbound fraction in plasma (r=0.95 and 0.80, respectively). Thus DZ and DMDZ concentrations in CSF, presumed to reflect concentrations at the site of action, are determined by unbound plasma concentrations. The intensity of pharmacologic action is more likely to correlate with unbound than with total plasma concentrations.
Keywords:Diazepam  Benzodiazepines  Cerebrospinal fluid  Blood-brain barrier  Protein binding
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号